Drugs / Ozempic pill
Prices checked Oct 17, 2026Ozempic pill
semaglutide · Novo Nordisk. What it costs at every strength, what insurance and Medicare cover, and where to buy it.
Price at each strength
Coverage at a glance
The details
- Tablet: lowest listed self-pay price $149 per month (1.5 mg); highest regular price $299 per month.1
- Medicare GLP-1 Bridge: Ozempic pill is not on the program's list of covered drugs.2
- With commercial insurance: Novo Nordisk's savings offer lets you pay as little as $25, with at most $100 off per month, listed as "for up to 3 months".34
Ozempic Tablet: every strength, with conditions
Sold through NovoCare Pharmacy (Novo Nordisk self-pay). About this channel.
| Strength | Price per month | Conditions in the official listing | List price (WAC) |
|---|---|---|---|
| 1.5 mg | $149 | — | $1,027.51 |
| 4 mg | $199 | — | $1,027.51 |
| 9 mg | $299 | — | $1,027.51 |
“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month defined as 1 bottle of 30 tablets. Novo Nordisk reserves the right to modify or cancel at any time. See full terms and conditions.”
If you have Medicare or Medicaid
The official wording on government insurance is not the same on every page. Read the offer terms before counting on a self-pay price.
“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month defined as 1 bottle of 30 tablets. Novo Nordisk reserves the right to modify or cancel at any time. See full terms and conditions.”
Price history
Tracking began Oct 17, 2026. A new row appears only after a person has checked a change against the official page. All changes · Download CSV
| Checked | Form | Strengths | Lowest | Highest regular |
|---|---|---|---|---|
| 2026-10-17 | Tablet | 1.5, 4, 9 mg | $149 | $299 |
From the FDA label
Word for word from the label on DailyMed: what the drug is approved for, the strengths and pack sizes (how many doses come in one carton or bottle), and the label's dose schedule.
FDA-approved uses · label 1
RYBELSUS and OZEMPIC tablets are indicated:
- • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- • to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events.
Dosage forms and strengths · label 3
RYBELSUS (semaglutide) tablets are available as:
- •3 mg: white to light yellow, oval shaped debossed with “3” on one side and “novo” on the other side.
- •7 mg: white to light yellow, oval shaped debossed with “7” on one side and “novo” on the other side.
- •14 mg: white to light yellow, oval shaped debossed with “14” on one side and “novo” on the other side.
OZEMPIC (semaglutide) tablets are available as:
- •1.5 mg: white to light yellow, round shaped debossed with “1.5” on one side and “novo” on the other side.
- •4 mg: white to light yellow, round shaped debossed with “4” on one side and “novo” on the other side.
- •9 mg: white to light yellow, round shaped debossed with “9” on one side and “novo” on the other side.
Dose schedule in the label · label 2.2
RYBELSUS: Recommended Dosage
Follow the RYBELSUS starting, escalation, and maintenance dosage described below to reduce the risk of gastrointestinal (GI) adverse reactions [see Warnings and Precautions ( 5.6 ), Adverse Reactions ( 6.1 )] :
- • Starting Dosage (Initiation Phase) (Days 1 to 30): The recommended starting dosage is 3 mg orally once daily (this dosage is not effective for glycemic control).
- • Escalation and Maintenance Dosage (Days 31 and beyond):
- o Days 31 to 60: Increase the dosage to 7 mg orally once daily.
- o On Day 61 or thereafter, if:
- ▪ No additional glycemic control is needed, maintain the dosage at 7 mg orally once daily.
- ▪ Additional glycemic control is needed, increase the dosage to 14 mg orally once daily.
OZEMPIC Tablets: Recommended Dosage
Follow the OZEMPIC tablets starting, escalation, and maintenance dosage described below to reduce the risk of GI adverse reactions [see Warnings and Precautions ( 5.6 ), Adverse Reactions ( 6.1 )] :
- • Starting Dosage (Initiation Phase) (Days 1 through 30): The recommended starting dosage is 1.5 mg orally once daily (this dosage is not effective for glycemic control).
- • Escalation and Maintenance Dosage (Days 31 and beyond):
- o Days 31 to 60: Increase the dosage to 4 mg orally once daily.
- o On Day 61 or thereafter, if:
- ▪ No additional glycemic control is needed, maintain the dosage at 4 mg orally once daily.
- ▪ Additional glycemic control is needed, increase the dosage to 9 mg orally once daily.
How it is supplied (pack sizes) · label 16
How Supplied
RYBELSUS strengths are available as follows:
Tablet Strength | Description | Package Configuration | NDC Number |
3 mg | White to light yellow, oval shaped debossed with “3” on one side and “novo” on the other side | Bottle of 30 tablets | 0169-4303-30 |
7 mg | White to light yellow, oval shaped debossed with “7” on one side and “novo” on the other side | Bottle of 30 tablets | 0169-4307-30 |
14 mg | White to light yellow, oval shaped debossed with “14” on one side and “novo” on the other side | Bottle of 30 tablets | 0169-4314-30 |
OZEMPIC tablet strengths are available as follows:
Tablet Strength | Description | Package Configuration | NDC Number |
1.5 mg | White to light yellow, round shaped debossed with “1.5” on one side and “novo” on the other side | Bottle of 30 tablets | 0169-1715-30 |
4 mg | White to light yellow, round shaped debossed with “4” on one side and “novo” on the other side | Bottle of 30 tablets | 0169-1704-30 |
9 mg | White to light yellow, round shaped debossed with “9” on one side and “novo” on the other side | Bottle of 30 tablets | 0169-1709-30 |
Storage and Handling
Store RYBELSUS and OZEMPIC tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store and dispense in the original bottle.
Store tablets in the original bottle until use to protect tablets from moisture. Store product in a dry place away from moisture.
Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.
Official sources for this page (4)
“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month defined as 1 bottle of 30 tablets. Novo Nordisk reserves the right to modify or cancel at any time. See full terms and conditions.”
TrumpRx.gov: Ozempic Tablet listing · as of Oct 17, 2026“Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).”
Medicare.gov: Weight loss drugs · as of Oct 17, 2026“Pay as little as $25, subject to a maximum savings of $100/month. Government beneficiaries excluded.”
NovoCare Pharmacy · as of Oct 17, 2026“Pay as little as $25 per month for up to 3 months”
NovoCare Pharmacy · as of Oct 17, 2026